Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Delanzomib |
| Trade Name | |
| Synonyms | CEP-18770|CEP18770|NPH-007098 |
| Drug Descriptions |
Delanzomib (CEP-18770) inhibits proteosome chymotrypsin-like activity, potentially resulting in increased tumor cell death (PMID: 18057228, PMID: 25935605, PMID: 23058787, PMID: 28140719). |
| DrugClasses | |
| CAS Registry Number | 847499-27-8 |
| NCIT ID | C74075 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Delanzomib | Delanzomib | 0 | 0 |
| Delanzomib + Tinostamustine | Delanzomib Tinostamustine | 0 | 0 |